Showing results (1581-1590 of 2,171) with videos related to

Sort By:
Pageof 218
European Heart Journal|March 6, 2008
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudyMichael A McDonald, Yuling Fu, Uwe Zeymer, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|August 9, 2024
Teledermatology Use in the Elderly: An Analysis of Teledermatology Utilization Patterns Across Age GroupsAudrey Hao, Kaviyon Sadrolashrafi, Robin Kikuchi, et al.
Dermatology and Therapy|December 9, 2022
Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis RegistryApril W Armstrong, Timothy Fitzgerald, Robert R McLean, et al.
American Heart Journal|March 5, 2013
Incidence of heart failure and mortality after acute coronary syndromesPadma Kaul, Justin A Ezekowitz, Paul W Armstrong, et al.
Critical Care Medicine|June 22, 2010
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention TrialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
Journal of Clinical Microbiology|February 4, 2011
Discovery and phylogenetic analysis of novel members of class b enterotoxigenic Escherichia coli adhesive fimbriaeRania A Nada, Hind I Shaheen, Sami B Khalil, et al.
Journal of the American Academy of Dermatology|August 18, 2014
Set-back versus buried vertical mattress suturing: results of a randomized blinded trialAudrey S Wang, Rebecca Kleinerman, April W Armstrong, et al.
JAMA|April 14, 2005
Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomesRajendra H Mehta, John H Alexander, Frans Van de Werf, et al.
Therapeutic Drug Monitoring|May 21, 2005
NAT2*5/*5 genotype (341T>C) is a potential risk factor for schistosomiasis-associated bladder cancer in EgyptiansEhab S El Desoky, Yasser M AbdelSalam, Ragaa H Salama, et al.
The American Journal of Cardiology|August 15, 1993
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study GroupA Haq, C D Morgan, R F Wilson, et al.
Pageof 218